Back to today’s briefing

Story perspectives

Bayer Faces €4B Hit Amid Job Cuts and Legal Woes

11/13/2025

33 5

Summary

Story summary

Bayer AG, the German pharmaceutical and life sciences company, said on November 12, 2025 that one-off costs from litigation provisions and executive buyouts will reduce EBITDA by 3.5 to 4 billion euros, up from 2.5 to 3.5.
It reaffirmed its 2025 EBITDA forecast of 9.7–10.2 billion euros.
Bayer cut about 13,500 jobs to streamline operations.
Recent litigation setbacks include a $611 million Roundup verdict and a $185 million PCB verdict.

1 of 1

Story summary

Bayer AG, the German pharmaceutical and life sciences company, said on November 12, 2025 that one-off costs from litigation provisions and executive buyouts will reduce EBITDA by 3.5 to 4 billion euros, up from 2.5 to 3.5.
It reaffirmed its 2025 EBITDA forecast of 9.7–10.2 billion euros.
Bayer cut about 13,500 jobs to streamline operations.
Recent litigation setbacks include a $611 million Roundup verdict and a $185 million PCB verdict.